Literature DB >> 14623763

Electrophysiological effects of 5-hydroxytryptamine on isolated human atrial myocytes, and the influence of chronic beta-adrenoceptor blockade.

Davide Pau1, Antony J Workman, Kathleen A Kane, Andrew C Rankin.   

Abstract

5-Hydroxytryptamine (5-HT) has been postulated to play a proarrhythmic role in the human atria via stimulation of 5-HT4 receptors. The aims of this study were to examine the effects of 5-HT on the L-type Ca2+ current (ICaL) action potential duration (APD), the effective refractory period (ERP) and arrhythmic activity in human atrial cells, and to assess the effects of prior treatment with beta-adrenoceptor antagonists. Isolated myocytes, from the right atrial appendage of 27 consenting patients undergoing cardiac surgery who were in sinus rhythm, were studied using the whole-cell perforated patch-clamp technique at 37 degrees C. 5-HT (1 nm-10 microm) caused a concentration-dependent increase in ICaL, which was potentiated in cells from beta-blocked (maximum response to 5-HT, Emax=299+/-12% increase above control) compared to non-beta-blocked patients (Emax=220+/-6%, P<0.05), but with no change in either the potency (log EC50: -7.09+/-0.07 vs -7.26+/-0.06) or Hill coefficient (nH: 1.5+/-0.6 vs 1.5+/-0.3) of the 5-HT concentration-response curve. 5-HT (10 microm) produced a greater increase in the APD at 50% repolarisation (APD50) in cells from beta-blocked patients (of 37+/-10 ms, i.e. 589+/-197%) vs non-beta-blocked patients (of 10+/-4 ms, i.e. 157+/-54%; P<0.05). Both the APD90 and the ERP were unaffected by 5-HT. Arrhythmic activity was observed in response to 5-HT in five of 17 cells (29%) studied from beta-blocked, compared to zero of 16 cells from the non-beta-blocked patients (P<0.05). In summary, the 5-HT-induced increase in calcium current was associated with a prolonged early plateau phase of repolarisation, but not late repolarisation or refractoriness, and the enhancement of these effects by chronic beta-adrenoceptor blockade was associated with arrhythmic potential.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14623763      PMCID: PMC1574154          DOI: 10.1038/sj.bjp.0705553

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  29 in total

Review 1.  Review article: cardiac adverse effects of gastrointestinal prokinetics.

Authors:  M Tonini; F De Ponti; A Di Nucci; F Crema
Journal:  Aliment Pharmacol Ther       Date:  1999-12       Impact factor: 8.171

Review 2.  Peripheral 5-HT4 receptors.

Authors:  S S Hegde; R M Eglen
Journal:  FASEB J       Date:  1996-10       Impact factor: 5.191

3.  World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects.

Authors: 
Journal:  Cardiovasc Res       Date:  1997-07       Impact factor: 10.787

Review 4.  Atrial electrophysiological remodeling caused by rapid atrial activation: underlying mechanisms and clinical relevance to atrial fibrillation.

Authors:  S Nattel
Journal:  Cardiovasc Res       Date:  1999-05       Impact factor: 10.787

5.  Selective beta1-adrenoceptor blockade enhances the activity of the stimulatory G-protein in human atrial myocardium.

Authors:  T Wang; C Plumpton; M J Brown
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

6.  Transient outward and delayed rectifier currents in canine atrium: properties and role of isolation methods.

Authors:  L Yue; J Feng; G R Li; S Nattel
Journal:  Am J Physiol       Date:  1996-06

7.  Electrophysiological and antiarrhythmic effects of the atrial selective 5-HT(4) receptor antagonist RS-100302 in experimental atrial flutter and fibrillation.

Authors:  M M Rahme; B Cotter; E Leistad; M K Wadhwa; R Mohabir; A P Ford; R M Eglen; G K Feld
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

8.  The shape of human atrial action potential accounts for different frequency-related changes in vitro.

Authors:  A A Dawodu; F Monti; K Iwashiro; M Schiariti; R Chiavarelli; P E Puddu
Journal:  Int J Cardiol       Date:  1996-06       Impact factor: 4.164

9.  Inactivation of (Gialpha) proteins increases arrhythmogenic effects of beta-adrenergic stimulation in the heart.

Authors:  M Grimm; S Gsell; C Mittmann; M Nose; H Scholz; J Weil; T Eschenhagen
Journal:  J Mol Cell Cardiol       Date:  1998-10       Impact factor: 5.000

10.  Sensitization of human atrial 5-HT4 receptors by chronic beta-blocker treatment.

Authors:  L Sanders; J A Lynham; B Bond; F del Monte; S E Harding; A J Kaumann
Journal:  Circulation       Date:  1995-11-01       Impact factor: 29.690

View more
  13 in total

1.  Prucalopride is a partial agonist through human and porcine atrial 5-HT4 receptors: comparison with recombinant human 5-HT4 splice variants.

Authors:  Kurt A Krobert; Trond Brattelid; Finn Olav Levy; Alberto J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-07-13       Impact factor: 3.000

2.  Porcine left atrial and sinoatrial 5-HT(4) receptor-induced responses: fading of the response and influence of development.

Authors:  Joris H De Maeyer; Roel Straetemans; Jan A J Schuurkes; Romain A Lefebvre
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

3.  Effects of treatment with a 5-HT4 receptor antagonist in heart failure.

Authors:  J A K Birkeland; I Sjaastad; T Brattelid; E Qvigstad; E R Moberg; K A Krobert; R Bjørnerheim; T Skomedal; O M Sejersted; J-B Osnes; F O Levy
Journal:  Br J Pharmacol       Date:  2006-12-11       Impact factor: 8.739

Review 4.  Cardiac adrenergic control and atrial fibrillation.

Authors:  Antony J Workman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-12-04       Impact factor: 3.000

5.  Surprises from a cardiac 5-HT₄TG mouse: spontaneous atrial arrhythmias by endogenous 5-HT of atrial origin? Different mechanism of arrhythmias through 5-HT₄ receptors and β-adrenoceptors?

Authors:  Alberto J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-05       Impact factor: 3.000

6.  Functional serotonin 5-HT4 receptors in porcine and human ventricular myocardium with increased 5-HT4 mRNA in heart failure.

Authors:  Trond Brattelid; Eirik Qvigstad; James A Lynham; Peter Molenaar; Halfdan Aass; Odd Geiran; Tor Skomedal; Jan-Bjørn Osnes; Finn Olav Levy; Alberto J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-09-07       Impact factor: 3.000

7.  Ontogenic changes of the control by phosphodiesterase-3 and -4 of 5-HT responses in porcine heart and relevance to human atrial 5-HT(4) receptors.

Authors:  Alejandro Galindo-Tovar; Maria Luisa Vargas; Elisa Escudero; Alberto J Kaumann
Journal:  Br J Pharmacol       Date:  2009-01-19       Impact factor: 8.739

8.  Platelets and cardiac arrhythmia.

Authors:  Jonas S S G de Jong; Lukas R C Dekker
Journal:  Front Physiol       Date:  2010-12-30       Impact factor: 4.566

9.  Cellular bases for human atrial fibrillation.

Authors:  Antony J Workman; Kathleen A Kane; Andrew C Rankin
Journal:  Heart Rhythm       Date:  2008-01-17       Impact factor: 6.343

10.  Effects of human atrial ionic remodelling by β-blocker therapy on mechanisms of atrial fibrillation: a computer simulation.

Authors:  Sanjay R Kharche; Tomas Stary; Michael A Colman; Irina V Biktasheva; Antony J Workman; Andrew C Rankin; Arun V Holden; Henggui Zhang
Journal:  Europace       Date:  2014-08-01       Impact factor: 5.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.